Back to O& Oppenheimer & Co Inc
OTLK
7 quarters
Position history for O&Oppenheimer & Co Inc's holdings in Outlook Therapeutics, Inc.
Yes. Oppenheimer holds 16,500 shares of OTLK (Outlook Therapeutics), worth $9,463, as of its Q3 2026 13F filing. It increased the position by 2,500 shares (+17.9%) from Q2 2026. Oppenheimer has held OTLK since Q1 2026, across 3 quarterly 13F filings.
Current Value
$9,463
Current Shares
16,500
Total Value Change
-$7,007
Total Shares Change
+3,000
Quarter-by-Quarter History